Alprazolam (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Alprazolam" in Italian language version.

refsWebsite

Global rank Italian rank

31nih.gov

4^th place

9^th place

9doi.org

2^nd place

7^th place

5archive.org

6^th place

8^th place

4oadoi.org

799^th place

22^nd place

2web.archive.org

1^st place

2pharmamedix.com

low place

1,509^th place

2jamanetwork.com

2,650^th place

2,089^th place

1psychiatrist.com

low place

1eurekaselect.com

low place

1karger.com

4,489^th place

2,787^th place

1annals.org

low place

7,527^th place

annals.org

Almeida JC, Grimsley EW, Coma from the health food store: interaction between kava and alprazolam, in Annals of Internal Medicine, vol. 125, n. 11, dicembre 1996, pp. 940-1, PMID 8967683. URL consultato il 27 dicembre 2014.

archive.org

Rush CR, Higgins ST, Bickel WK, Hughes JR, Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review, in Neurosci Biobehav Rev, vol. 17, n. 3, 1993, pp. 277-85, DOI:10.1016/S0149-7634(05)80011-9, PMID 7903805. URL consultato il 27 dicembre 2014.
Lydiard RB, Laraia MT, Ballenger JC, Howell EF, Emergence of depressive symptoms in patients receiving alprazolam for panic disorder, in The American Journal of Psychiatry, vol. 144, n. 5, maggio 1987, pp. 664-5, PMID 3578580.
Iqbal MM, Sobhan T, Ryals T, Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant, in Psychiatr Serv, vol. 53, n. 1, gennaio 2002, pp. 39-49, PMID 11773648.
Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ, Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk, in Br J Clin Pharmacol, vol. 40, n. 3, settembre 1995, pp. 231-6, PMC 1365102, PMID 8527284.
von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI, Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine, in British Journal of Clinical Pharmacology, vol. 38, n. 1, luglio 1994, pp. 23-31, PMC 1364833, PMID 7946933.

doi.org

dx.doi.org

Skelton KH, Nemeroff CB, Owens MJ, Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression, in J. Neurosci., vol. 24, n. 42, ottobre 2004, pp. 9303-12, DOI:10.1523/JNEUROSCI.1737-04.2004, PMID 15496666.
Bentué-Ferrer D, Reymann JM, Tribut O, Allain H, Vasar E, Bourin M, Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam, in European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, vol. 11, n. 1, febbraio 2001, pp. 41-50, DOI:10.1016/S0924-977X(00)00137-1, PMID 11226811.
Abali H, Oyan B, Guler N, Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer, in Chemotherapy, vol. 51, n. 5, agosto 2005, pp. 280-5, DOI:10.1159/000087455, PMID 16103667.
Moylan S, Giorlando F, Nordfjærn T, Berk M, The role of alprazolam for the treatment of panic disorder in Australia, in Aust N Z J Psychiatry, vol. 46, n. 3, marzo 2012, pp. 212-24, DOI:10.1177/0004867411432074, PMID 22391278.
Rush CR, Higgins ST, Bickel WK, Hughes JR, Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review, in Neurosci Biobehav Rev, vol. 17, n. 3, 1993, pp. 277-85, DOI:10.1016/S0149-7634(05)80011-9, PMID 7903805. URL consultato il 27 dicembre 2014.
van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II, Alprazolam for depression, in The Cochrane Database of Systematic Reviews, vol. 7, 2012, pp. CD007139, DOI:10.1002/14651858.CD007139.pub2, PMID 22786504. URL consultato il 27 dicembre 2014.
Hori A, Pharmacotherapy for personality disorders, in Psychiatry Clin. Neurosci., vol. 52, n. 1, febbraio 1998, pp. 13-9, DOI:10.1111/j.1440-1819.1998.tb00967.x, PMID 9682928.
Dresser GK, Spence JD, Bailey DG, Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition, in Clinical Pharmacokinetics, vol. 38, n. 1, gennaio 2000, pp. 41-57, DOI:10.2165/00003088-200038010-00003, PMID 10668858. URL consultato il 27 dicembre 2014.
Greenblatt DJ, Wright CE, Clinical pharmacokinetics of alprazolam. Therapeutic implications, in Clinical Pharmacokinetics, vol. 24, n. 6, giugno 1993, pp. 453-71, DOI:10.2165/00003088-199324060-00003, PMID 8513649. URL consultato il 27 dicembre 2014.

eurekaselect.com

Mandrioli R, Mercolini L, Raggi MA, Benzodiazepine metabolism: an analytical perspective, in Current Drug Metabolism, vol. 9, n. 8, ottobre 2008, pp. 827-44, PMID 18855614.

jamanetwork.com

jama.jamanetwork.com

Weddington WW, Carney AC, Alprazolam abuse during methadone maintenance therapy, in JAMA, vol. 257, n. 24, giugno 1987, p. 3363, PMID 3586263. URL consultato il 27 dicembre 2014.

archpsyc.jamanetwork.com

Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD, Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety, in Arch. Gen. Psychiatry, vol. 45, n. 5, maggio 1988, pp. 423-8, PMID 3358644. URL consultato il 26 dicembre 2014.

karger.com

Abali H, Oyan B, Guler N, Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer, in Chemotherapy, vol. 51, n. 5, agosto 2005, pp. 280-5, DOI:10.1159/000087455, PMID 16103667.

nih.gov

ncbi.nlm.nih.gov

Skelton KH, Nemeroff CB, Owens MJ, Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression, in J. Neurosci., vol. 24, n. 42, ottobre 2004, pp. 9303-12, DOI:10.1523/JNEUROSCI.1737-04.2004, PMID 15496666.
Chouinard G, Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound, in J Clin Psychiatry, 65 Suppl 5, 2004, pp. 7-12, PMID 15078112.
Arvat E, Giordano R, Grottoli S, Ghigo E, Benzodiazepines and anterior pituitary function, in Journal of Endocrinological Investigation, vol. 25, n. 8, settembre 2002, pp. 735-47, PMID 12240908.
Mandrioli R, Mercolini L, Raggi MA, Benzodiazepine metabolism: an analytical perspective, in Current Drug Metabolism, vol. 9, n. 8, ottobre 2008, pp. 827-44, PMID 18855614.
Bentué-Ferrer D, Reymann JM, Tribut O, Allain H, Vasar E, Bourin M, Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam, in European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, vol. 11, n. 1, febbraio 2001, pp. 41-50, DOI:10.1016/S0924-977X(00)00137-1, PMID 11226811.
Otani K, [Cytochrome P450 3A4 and Benzodiazepines], in Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica, vol. 105, n. 5, 2003, pp. 631-42, PMID 12875231.
Abali H, Oyan B, Guler N, Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer, in Chemotherapy, vol. 51, n. 5, agosto 2005, pp. 280-5, DOI:10.1159/000087455, PMID 16103667.
Kris MG, Pisters KM, Hinkley L, Delayed emesis following anticancer chemotherapy, in Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 2, n. 5, settembre 1994, pp. 297-300, PMID 8000726.
Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators, in Br J Psychiatry, vol. 160, febbraio 1992, pp. 191–202; discussion 202–5, PMID 1540759.
Moylan S, Giorlando F, Nordfjærn T, Berk M, The role of alprazolam for the treatment of panic disorder in Australia, in Aust N Z J Psychiatry, vol. 46, n. 3, marzo 2012, pp. 212-24, DOI:10.1177/0004867411432074, PMID 22391278.
Weddington WW, Carney AC, Alprazolam abuse during methadone maintenance therapy, in JAMA, vol. 257, n. 24, giugno 1987, p. 3363, PMID 3586263. URL consultato il 27 dicembre 2014.
Rush CR, Higgins ST, Bickel WK, Hughes JR, Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review, in Neurosci Biobehav Rev, vol. 17, n. 3, 1993, pp. 277-85, DOI:10.1016/S0149-7634(05)80011-9, PMID 7903805. URL consultato il 27 dicembre 2014.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders, in World J. Biol. Psychiatry, vol. 3, n. 4, ottobre 2002, pp. 171-99, PMID 12516310.
van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II, Alprazolam for depression, in The Cochrane Database of Systematic Reviews, vol. 7, 2012, pp. CD007139, DOI:10.1002/14651858.CD007139.pub2, PMID 22786504. URL consultato il 27 dicembre 2014.
Lydiard RB, Laraia MT, Ballenger JC, Howell EF, Emergence of depressive symptoms in patients receiving alprazolam for panic disorder, in The American Journal of Psychiatry, vol. 144, n. 5, maggio 1987, pp. 664-5, PMID 3578580.
Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis G, Hippius H, Maier W, Shera D, Klerman G, Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo, in Eur Neuropsychopharmacol, vol. 4, n. 1, marzo 1994, pp. 47-53, PMID 8204996.
Hori A, Pharmacotherapy for personality disorders, in Psychiatry Clin. Neurosci., vol. 52, n. 1, febbraio 1998, pp. 13-9, DOI:10.1111/j.1440-1819.1998.tb00967.x, PMID 9682928.
Michel L, Lang JP, [Benzodiazepines and forensic aspects], in Encephale, vol. 29, n. 6, 2003, pp. 479-85, PMID 15029082. URL consultato il 26 dicembre 2014 (archiviato dall'url originale il 14 aprile 2020).
Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD, Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety, in Arch. Gen. Psychiatry, vol. 45, n. 5, maggio 1988, pp. 423-8, PMID 3358644. URL consultato il 26 dicembre 2014.
Rebound insomnia: a critical review., su ncbi.nlm.nih.gov.
Iqbal MM, Sobhan T, Ryals T, Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant, in Psychiatr Serv, vol. 53, n. 1, gennaio 2002, pp. 39-49, PMID 11773648.
Uzun S, Kozumplik O, Jakovljević M, Sedić B, Side effects of treatment with benzodiazepines (PDF), in Psychiatr Danub, vol. 22, n. 1, marzo 2010, pp. 90-3, PMID 20305598. URL consultato il 27 dicembre 2014 (archiviato dall'url originale il 27 dicembre 2014).
Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ, Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk, in Br J Clin Pharmacol, vol. 40, n. 3, settembre 1995, pp. 231-6, PMC 1365102, PMID 8527284.
Anderson PO, McGuire GG, Neonatal alprazolam withdrawal--possible effects of breast feeding, in DICP, vol. 23, n. 7-8, 1989, p. 614, PMID 2763587.
von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI, Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine, in British Journal of Clinical Pharmacology, vol. 38, n. 1, luglio 1994, pp. 23-31, PMC 1364833, PMID 7946933.
Dresser GK, Spence JD, Bailey DG, Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition, in Clinical Pharmacokinetics, vol. 38, n. 1, gennaio 2000, pp. 41-57, DOI:10.2165/00003088-200038010-00003, PMID 10668858. URL consultato il 27 dicembre 2014.
Greenblatt DJ, Wright CE, Clinical pharmacokinetics of alprazolam. Therapeutic implications, in Clinical Pharmacokinetics, vol. 24, n. 6, giugno 1993, pp. 453-71, DOI:10.2165/00003088-199324060-00003, PMID 8513649. URL consultato il 27 dicembre 2014.
Wang JS, DeVane CL, Pharmacokinetics and drug interactions of the sedative hypnotics, in Psychopharmacology Bulletin, vol. 37, n. 1, 2003, pp. 10-29, PMID 14561946.
Back DJ, Orme ML, Pharmacokinetic drug interactions with oral contraceptives, in Clinical Pharmacokinetics, vol. 18, n. 6, giugno 1990, pp. 472-84, PMID 2191822.
Almeida JC, Grimsley EW, Coma from the health food store: interaction between kava and alprazolam, in Annals of Internal Medicine, vol. 125, n. 11, dicembre 1996, pp. 940-1, PMID 8967683. URL consultato il 27 dicembre 2014.
Izzo AA, Ernst E, Interactions between herbal medicines and prescribed drugs: a systematic review, in Drugs, vol. 61, n. 15, 2001, pp. 2163-75, PMID 11772128.

oadoi.org

Skelton KH, Nemeroff CB, Owens MJ, Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression, in J. Neurosci., vol. 24, n. 42, ottobre 2004, pp. 9303-12, DOI:10.1523/JNEUROSCI.1737-04.2004, PMID 15496666.
Bentué-Ferrer D, Reymann JM, Tribut O, Allain H, Vasar E, Bourin M, Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam, in European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, vol. 11, n. 1, febbraio 2001, pp. 41-50, DOI:10.1016/S0924-977X(00)00137-1, PMID 11226811.
Moylan S, Giorlando F, Nordfjærn T, Berk M, The role of alprazolam for the treatment of panic disorder in Australia, in Aust N Z J Psychiatry, vol. 46, n. 3, marzo 2012, pp. 212-24, DOI:10.1177/0004867411432074, PMID 22391278.
Hori A, Pharmacotherapy for personality disorders, in Psychiatry Clin. Neurosci., vol. 52, n. 1, febbraio 1998, pp. 13-9, DOI:10.1111/j.1440-1819.1998.tb00967.x, PMID 9682928.

pharmamedix.com

Pharmamedix: Alprazolam Alprazolam - Avvertenze (Pharmamedix)
Alprazolam: interazioni

psychiatrist.com

article.psychiatrist.com

Chouinard G, Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound, in J Clin Psychiatry, 65 Suppl 5, 2004, pp. 7-12, PMID 15078112.

web.archive.org

Michel L, Lang JP, [Benzodiazepines and forensic aspects], in Encephale, vol. 29, n. 6, 2003, pp. 479-85, PMID 15029082. URL consultato il 26 dicembre 2014 (archiviato dall'url originale il 14 aprile 2020).
Uzun S, Kozumplik O, Jakovljević M, Sedić B, Side effects of treatment with benzodiazepines (PDF), in Psychiatr Danub, vol. 22, n. 1, marzo 2010, pp. 90-3, PMID 20305598. URL consultato il 27 dicembre 2014 (archiviato dall'url originale il 27 dicembre 2014).